Print Friendly, PDF & Email

NCT/Study#

NCT04091750 /

IST83

Phase II Study of Nivolumab/Ipilimumab plus Cabozantinib in Patients with Unresectable Advanced Melanoma

DISEASE GROUP:

Skin and Soft Tissue

current phase:

Phase II

STUDY STATUS:

Accepting Patients

Location:

Hackensack, NJ

For More information:

Call 201-518-3587